Who Owns Harmony Biosciences Holdings (HRMY)? 13F Institutional Holders (Q2 2026)

HRMY ranks #1929 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

327 institutions disclose a position in HRMY, but none treat it as a major bet — even venBio Partners LLC, its most concentrated holder, allocates just 3.3% of its own portfolio to it.

Wedge Capital Management L L P/nc has added to its HRMY position for two straight quarters, increasing it by $747.3K to reach $3.2M today.

HRMY is up 1.3% today, and institutions have been net buyers of $78.7M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

HRMY posted net income of $181.3M over the trailing twelve months, and currently trades at a P/E of 12.1.

• Profitable — net income of $181.3M over the trailing twelve months
• Revenue grew 24.3% year over year
• Net income improved year over year, from $180.9M to $181.3M
• Generated $348.2M in positive operating cash flow
• Current ratio of 3.60x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.46x equity — within a conventional range